Previous close | 17.07 |
Open | 17.16 |
Bid | 16.41 x 1800 |
Ask | 17.47 x 900 |
Day's range | 16.79 - 17.54 |
52-week range | 13.82 - 27.95 |
Volume | |
Avg. volume | 435,450 |
Market cap | 790.495M |
Beta (5Y monthly) | 2.43 |
PE ratio (TTM) | 33.22 |
EPS (TTM) | 0.51 |
Earnings date | 30 Jan 2024 - 05 Feb 2024 |
Forward dividend & yield | 0.04 (0.23%) |
Ex-dividend date | 03 May 2024 |
1y target est | 19.50 |
Q1 2024 Core Laboratories Inc Earnings Call
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2024 revenue of $129,600,000. Core's operating income was $8,600,000, with diluted earnings per share ("EPS") of $0.07, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $14,900,000, yielding operating margins of 12%, and EPS, ex-items, of $0.19. During the first quarter of 2024, the Company recorded: 1) appr